80岁男性膀胱内BCG免疫治疗后出现呼吸功能不全
一例80岁男性膀胱浅表性尿路上皮癌患者,接受膀胱内牛分枝杆菌BCG免疫治疗数月后,因发热、血尿及全身不适1周就诊急诊。
要点
- 膀胱内BCG免疫治疗后可出现发热、血尿等全身症状,需警惕播散性感染
- 免疫治疗后发热按尿路感染治疗无效时,应重新评估病因
- 发热寒战期间出现低氧性呼吸衰竭提示需ICU评估与呼吸支持
研究设计与样本
- 个案报告:1例80岁男性膀胱浅表性尿路上皮癌患者,接受膀胱内BCG免疫治疗数月。
主要发现
- 患者因发热、血尿和全身不适1周就诊急诊,初始按复杂性尿路感染予头孢菌素治疗,症状未改善。
临床怎么用
- 对接受膀胱内BCG免疫治疗并出现发热、血尿及呼吸道症状者,应警惕BCG相关播散性感染的可能。
- 初始抗感染治疗无效且出现低氧性呼吸衰竭时,应及时升级监护并评估ICU收治。
局限性
- 为单例个案报告,未提供诊断确认、治疗经过及结局等信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
An 80-year-old man came to the ED with fever, hematuria, and overall discomfort for 1 week. His medical history included a superficial urothelial carcinoma of the bladder for which he was adjunctively treated with intravesical Mycobacterium bovis BCG (bacillus Calmette-Guérin) immunotherapy for several months. The patient was admitted to the hospital and was initially treated with cephalosporins for a suspected complicated urinary tract infection, but his symptoms did not improve. Ten days after the initial admission, the patient developed hypoxemic respiratory failure during an episode of fever and cold chills and was admitted to the ICU.
引用
- Haselager D, Dorigo-Zetsma W, Schröder M, et al. An 80-Year-Old Man With Respiratory Insufficiency After Intravesical Mycobacterium bovis BCG Immunotherapy. Chest. 2023. PMID: 37558334. doi:10.1016/j.chest.2023.02.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。